Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q3 2020 · 10-Q
Revenue$15.28M$15.28M−0.8% vs Q3 2019 Net Income-$7.35M-$7.35MN/M vs Q3 2019 EPS Diluted-$0.10-$0.10N/M vs Q3 2019 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,918,000N/M Margins · derivedGross margin2.3%+2.4 pt vs Q3 2019
Operating margin-43.8%+7.8 pt vs Q3 2019
Net margin-48.1%+2.9 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 9, 2020 · 40 d after period end